Key facts
- Samsara BioCapital, L.P. filed SCHEDULE 13D/A for KALARIS THERAPEUTICS, INC. Common Stock, $0.0001 par value per share (KLRS).
- Disclosed ownership: 54%.
- Date of event: 20 May 2026.
Key filing fact
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Samsara BioCapital, L.P. | 45% | 10,657,028 | 0 | 10,657,028 | /s/ Srinivas Akkaraju | By Samsara BioCapital GP, LLC, its General Partner, By Srinivas Akkaraju, Managing Member | 0001699737 |
| Samsara BioCapital GP, LLC | 45% | 10,671,965 | 0 | 10,671,965 | /s/ Srinivas Akkaraju | By Srinivas Akkaraju, Managing Member | 0001888829 |
| Samsara Opportunity Fund, L.P. | 9.3% | 2,224,147 | 0 | 2,224,147 | /s/ Srinivas Akkaraju | By Samsara Opportunity Fund GP, LLC, its General Partner, By Srinivas Akkaraju, Managing Member | 0002086193 |
| Samsara Opportunity Fund GP, LLC | 9.3% | 2,224,147 | 0 | 2,224,147 | /s/ Srinivas Akkaraju | By Srinivas Akkaraju, Managing Member | 0002086456 |
| Srinivas Akkaraju | 54% | 12,900,583 | 8,000 | 12,900,583 | /s/ Srinivas Akkaraju | Srinivas Akkaraju | 0001253170 |
CIK / CUSIP context first